MYCN and neoplasm: Reactivity of patient or normal CTL to MYCN peptide was not investigated in this study, but it is conceivable that MYCN peptide-specific CTL can be generated using tumor mRNA DC transfection from NB patients carrying MYCN-amplified tumors.